Skip to main content

Table 1 Parameters used to estimate the health burden due to NCCa-associated epilepsy and headache (migraine and tension-type) in Angónia district

From: Assessment of the societal cost of Taenia solium in Angónia district, Mozambique

Parameter

Mean (95% UIb)

Distributions

Reference

Mortality due to epilepsy

per 1000

0.08 (0.076–0.084)

Uniform

(7.6e-05, 8.4e-05)

[28]

Prevalence of active epilepsy (%)

1.3 (0.8–1.9)

Beta

(22, 1701)

[15]

Proportions

 Epilepsy associated to NCC (%)

51 (43–59)

Uniform

(0.427, 0.592)

[15]

 Epilepsy patients receiving treatment (%)

15 (9.4–21)

Beta

(22, 129)

[15]

 Headache among people with lifetime epilepsy (%)

62 (54–70)

Beta

(94, 57)

[23]

 Migraine among people with headache and epilepsy (%)

39 (30–50)

Beta

(37, 57)

[23]

 Tension-type headache among people with headache and epilepsy (%)

61 (50–70)

Beta

(57, 37)

[23]

Disability weights

 Epilepsy

  

GBDc 2010 [31]

 Untreated

0.426 (0.286–0.565)

Uniform

(0.279, 0.572)

 

 Treated, seizure free

0.076 (0.048–0.105)

Uniform

(0.047, 0.106)

 

 Headache

  

GBDc 2013 [32]

 Migraine

0.441 (0.301–0.581)

Uniform

(0.294, 0.588)

 

 Tension-type

0.040 (0.023–0.056)

Uniform

(0.022, 0.057)

 
  1. a NCC neurocysticercosis; b UI uncertainty interval; c GBD 2010, 2013: Global Burden of Disease Study 2010 and 2013